RENAL SAFETY AND THE RISK OF NEPHROGENIC SYSTEMIC FIBROSIS WITH ATRIAL FIBRILLATION RADIOFREQUENCY ABLATION SHORTLY AFTER LATE GADOLINIUM ENHANCEMENT CARDIAC MAGNETIC RESONANCE IMAGING  by Harrison, Alexis et al.
E1249
JACC April 5, 2011
Volume 57, Issue 14
  QUALITY OF CARE AND OUTCOMES ASSESSMENT 
RENAL SAFETY AND THE RISK OF NEPHROGENIC SYSTEMIC FIBROSIS WITH ATRIAL FIBRILLATION 
RADIOFREQUENCY ABLATION SHORTLY AFTER LATE GADOLINIUM ENHANCEMENT CARDIAC MAGNETIC 
RESONANCE IMAGING
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 3:30 p.m.-4:45 p.m.
Session Title: Quality of Care: Atrial Fibrillation
Abstract Category: 44. Quality of Care
Session-Poster Board Number: 1134-150
Authors: Alexis Harrison, Christopher J. McGann, Nazem Akoum, Brent Wilson, Jessiciah Windfelder, LeeAnn Spencer, Nathan S. Burgon, Nassir F. 
Marrouche, Comprehensive Arrhythmia and Research Management (CARMA) Center, University of Utah, Salt Lake City, UT
Background: Nephrogenic Systemic Fibrosis (NSF) is a debilitating disease of collagen deposition in skin and other organ systems associated with 
gadolinium exposure in patients with severely reduced renal function. No studies have examined the safety of radiofrequency ablation (RFA) with 
circulating and tissue gadolinium or the incidence of NSF after such an ablation. Late gadolinium enhancement (LGE) cardiac magnetic resonance 
imaging (cMRI) is often performed just prior to an ablation, and theoretically, by increasing local blood and tissue temperatures, RFA could increase 
the concentration of toxic free Gd3+ ions in circulation and risk triggering NSF.
Methods: From 2007 to present, 233 patients were identified in two groups, 73 patients who had RFA within 10 hours after a LGE-cMRI and 160 
patients who had RFA between 10 and 24 hours after a LGE-cMRI. All patients underwent cMRI on a 1.5-T Avanto or a 3-T Verio clinical scanner using 
0.1mmol/kg Multihance contrast agent (Bracco Diagnostic, Inc, Princeton, NJ). Full dose of contrast was given to all patients with an estimated 
glomerular filtration rate (GFR) of >60. Patients with an estimated GFR of 30-60 were given a half dose of contrast. RFA was performed with lesions 
delivered using 30-50W with a max temperature of 50° Celsius for duration of 10 sec (max 15 sec).
Results:  Of the 73 patients who had RFA within 10 hours after gadolinium exposure, 10 patients (16%) had a GFR of 30-60. Of the 160 patients 
who had RFA between 10 and 24 hours after RFA, 24 patients (15%) had a GFR of 30-60. Routine histories and physical examinations were 
performed at each follow-up appointment, and no adverse effects of LGE cMRI prior to ablation or cases of clinically significant NSF have been 
identified in this patient population.
Conclusions:  From our preliminary experience, LGE cMRI prior to RFA in patients with GFR of >30 is safe and not associated with NSF. We found 
no adverse outcomes or evidence of NSF in patients who underwent cMRI within 24 hours prior to RFA. This suggests that the heating of circulating 
gadolinium contrast during ablation does not significantly increase the concentration of Gd3+ ions or trigger NSF.
